Alkermes (ALKS) Return on Invested Capital Growth (3y) (2014 - 2025)
Alkermes (ALKS) Return on Invested Capital Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.88 Bn | 32.14 Bn | 1.97 Bn | 1.00 |
| 3 | Zoetis | 32.64 Bn | 30.70 Bn | 1.62 Bn | -2.00 |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 0.00 |
| 5 | United Therapeutics | 23.04 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.37 Bn | 18.57 Bn | 1.16 Bn | 0.00 |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.45 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 4.00 |
| 10 | Alkermes | 8.76 Bn | 8.25 Bn | 331.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 78.00 |
| Mar 31, 2025 | 44.00 |
| Dec 31, 2024 | 32.00 |
| Sep 30, 2024 | 35.00 |
| Jun 30, 2024 | 35.00 |
| Mar 31, 2024 | 54.00 |
| Dec 31, 2023 | 53.00 |
| Sep 30, 2023 | 46.00 |
| Jun 30, 2023 | 37.00 |
| Mar 31, 2023 | 7.00 |
| Dec 31, 2022 | 14.00 |
| Sep 30, 2022 | 15.00 |
| Jun 30, 2022 | 21.00 |
| Mar 31, 2022 | 20.00 |
| Dec 31, 2021 | 18.00 |
| Sep 30, 2021 | 2.00 |
| Jun 30, 2021 | 3.00 |
| Mar 31, 2021 | 2.00 |
| Dec 31, 2020 | 1.00 |
| Sep 30, 2020 | 5.00 |